首页/数据集/Promoter methylome and integrative transcriptome profiling identify key epigenetics-regulated genes in human HCCs [methylation]

Promoter methylome and integrative transcriptome profiling identify key epigenetics-regulated genes in human HCCs [methylation]

ChEBI2014-07-01 更新2026-07-21 收录

肝癌表观基因组学

癌症生物标志物

数据链接：

https://www.ebi.ac.uk/biostudies/ArrayExpress/studies/E-GEOD-55752 数据链接链接失效反馈

官方服务：

资源简介：

Promoter methylome and integrative transcriptome profiling identify key epigenetics-regulated genes in human HCCs [methylation]

应用场景：

创建时间：

2014-07-01

癌症生物标志物

肿瘤分期

aT-primary tumor: T2, tumor confined within prostate; T3, tumor extends through the prostate caspsule and T4, Tumor is fixed or invades adjacent structures other than seminal vesicles.

NIAID Data Ecosystem30

Table_7_Pathway Instability Is an Effective New Mutation-Based Type of Cancer Biomarkers.XLSX

癌症生物标志物

通路突变分析

DNA mutations play a crucial role in cancer development and progression. Mutation profiles vary dramatically in different cancer types and between individual tumors. Mutations of several individual ge

NIAID Data Ecosystem20

DataSheet4_A systematic pan-cancer analysis reveals the clinical prognosis and immunotherapy value of C-X3-C motif ligand 1 (CX3CL1).ZIP

癌症生物标志物

肿瘤免疫治疗

It is now widely known that C-X3-C motif ligand 1 (CX3CL1) plays an essential part in the process of regulating pro-inflammatory cells migration across a wide range of inflammatory disorders, includin

NIAID Data Ecosystem00

DataSheet_2_Integrated bioinformatics analysis of IFITM1 as a prognostic biomarker and investigation of its immunological role in prostate adenocarcinoma.zip

癌症生物标志物

肿瘤免疫治疗靶点

IntroductionProstate adenocarcinoma (PRAD) is a highly aggressive malignancy with high mortality and poor prognosis, and its potential mechanism remains unclear. Our study aimed to identify novel mark

NIAID Data Ecosystem20

Additional file 3 of Metabolomics assisted by transcriptomics analysis to reveal metabolic characteristics and potential biomarkers associated with treatment response of neoadjuvant therapy with TCbHP regimen in HER2 + breast cancer

癌症生物标志物

代谢组学转录组学整合分析

Supplementary Material 3

NIAID Data Ecosystem10